Maynard Um
-
-
-
-
-
-
-
Natera completes enrollment in heart transplant trial testing blood-based monitoring
-
-
-
-
-
-
-
Natera reports significant survival benefit in ALTAIR colorectal cancer trial
-
-
-
-
-
-
-
Natera (NTRA) files for 1.95M share offering by selling stockholders
-
-
-
-
-
-
-
Natera (NTRA) Misses Q3 EPS by 27c; offers guidance
-
-
-
-
-
-
-
Natera enrollment exceeds 1,600 patients in single gene NIPT trial
-
-
-
-
-
-
-
Natera launches AI foundation models for oncology drug development
-
-
-
-
-
-
-
Natera launches noninvasive prenatal test for inherited conditions
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

